The global Sodium Reduction Ingredient Market is projected to grow from USD 6.3 billion in 2026 to USD 11.5 billion by 2036, expanding at a CAGR of ...
When we think about highly sensitive medical testing, we often imagine a hospital laboratory filled with large instruments, trained technicians, and carefully controlled conditions. This is especially ...
Researchers at Tokushima University have demonstrated single-channel wireless transmission at 112 Gbps in the 560 GHz band ...
SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...
A collaborative research team from Kanazawa University and Kyoto University reports the successful visualization of how densely assembled macrocyclic host molecules cooperatively capture guest ...
Emerging growth opportunities in the next-generation immune checkpoint inhibitors market include the development of therapies targeting novel immune pathways employed to tackle cancer resistance ...
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced full enrollment ...
ADM explains why cutting sugar, sodium and artificial ingredients now requires a holistic reformulation strategy that ...
Significantly lower TLF rates (2.8% versus 7.8%, p=0.020) with DynamX® compared to Resolute Onyx DES with no new events in bioadaptor arm between 3 and 4 years 88% reduction in Cardiovascular Death (0 ...
Advanced monitoring of key baking variables allows producers to drive throughput without sacrificing product consistency.
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the grant of a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results